[artículo] 
inThe Canadian Journal of Psychiatry > Año 1998 Vol. 43 - No.5 (Junio) . - pp. 466–472

Título :	The use of clozapine in the treatment of aggressive schizophrenia
Tipo de documento:	texto impreso
Autores:	Horacio Rian Hector, Autor
Fecha de publicación:	2022
Artículo en la página:	pp. 466–472
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Agresión, Antipsicóticos, Clozapina, Farmacoterapia, Psiquiatría forense, Restricción física, Esquizofrenia, Psicología esquizofrénica, Aislamiento social.
Resumen:	The atypical antipsychotic drug clozapine was introduced to clinical practice in 1972. It is a dibenzodiazepine derivative with, among other known receptor site activities, a relatively high D1/D2 receptor affinity ratio. The serious side effects of bone marrow suppression and agranulocytosis delayed the acceptance of clozapine into common clinical practice but scrupulous application of a monitoring protocol led to adequate protection from these side effects.
Link:	./index.php?lvl=notice_display&id=29268

[artículo] The use of clozapine in the treatment of aggressive schizophrenia [texto impreso] / Horacio Rian Hector, Autor . - 2022 . - pp. 466–472.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The Canadian Journal of Psychiatry > Año 1998 Vol. 43 - No.5 (Junio) . - pp. 466–472

Palabras clave:	Agresión, Antipsicóticos, Clozapina, Farmacoterapia, Psiquiatría forense, Restricción física, Esquizofrenia, Psicología esquizofrénica, Aislamiento social.
Resumen:	The atypical antipsychotic drug clozapine was introduced to clinical practice in 1972. It is a dibenzodiazepine derivative with, among other known receptor site activities, a relatively high D1/D2 receptor affinity ratio. The serious side effects of bone marrow suppression and agranulocytosis delayed the acceptance of clozapine into common clinical practice but scrupulous application of a monitoring protocol led to adequate protection from these side effects.
Link:	./index.php?lvl=notice_display&id=29268